Prazosin Dosing Guidelines

Introduction to Prazosin Use

The American Urological Association guidelines explicitly state that data are insufficient to support prazosin use for benign prostatic hyperplasia, instead recommending alfuzosin, doxazosin, tamsulosin, or terazosin, which have established efficacy 1
Prazosin is recommended for PTSD-associated nightmares with Level A evidence 2

The first dose of prazosin should be given at bedtime to reduce first-dose syncope, with 2-3 times daily administration required for adequate 24-hour blood pressure control 3

Other alpha-1 blockers (doxazosin, terazosin, tamsulosin, alfuzosin) have been extensively studied and produce 4-6 point improvements in AUA Symptom Index 4
Lack of rigorous clinical trial data compared to other alpha-blockers is a reason prazosin is not recommended for BPH 1

Prazosin dosing for PTSD-related nightmares starts with 1 mg at bedtime, increasing by 1-2 mg every few days until effective, with an average effective dose of approximately 3 mg 2
Higher doses of prazosin, with a mean of 9.5-13.3 mg/day, are used in some trials for severe PTSD 2

Both elderly patients and those on multiple medications are at highest risk for orthostatic hypotension, requiring close monitoring of blood pressure, especially after initiation or dose changes 5
Combining prazosin with other CNS depressants (like doxepin) may cause additive sedation and orthostatic hypotension 5
Avoid abrupt discontinuation of prazosin, though it does not cause withdrawal phenomena like clonidine, and be cautious in elderly patients who are more susceptible to falls from orthostatic hypotension 3, 5

Prazosin requires 2-3 times daily dosing for adequate 24-hour blood pressure control—once-daily dosing is insufficient, as recommended by the American Heart Association 6, 7
Prazosin is a second-line agent for hypertension, not first-line therapy, due to its association with orthostatic hypotension, especially in older adults, as stated by the American College of Cardiology 6, 7
Alpha-1 blockers like prazosin may be considered as second-line agents in patients with concomitant benign prostatic hyperplasia (BPH), according to the American Urological Association 6, 7

Prazosin has Level A evidence and is recommended as first-line therapy for PTSD-related nightmares, with an average effective dose of approximately 3 mg, as recommended by the American Academy of Sleep Medicine 8
Higher doses (mean 9.5-13.3 mg/day) have been used in some trials for severe PTSD-associated nightmares, with veterans with chronic PTSD requiring mean doses of 13 ± 3 mg/day, as reported by the Journal of Clinical Sleep Medicine 8, 9
Active-duty soldiers may require mean bedtime doses of 15.6 ± 6.0 mg for men and 7.0 ± 3.5 mg for women, according to the Journal of Clinical Sleep Medicine 9